Comparison of goserelin and leuprolide in combined androgen blockade (CAB) for advanced prostate cancer.

被引：0
|
作者：
Sarosdy, MF
Schellhammer, PF
Block, NL
Soloway, MS
Venner, PM
Patterson, AL
Sharifi, R
Vogelzang, NJ
Chodak, GW
Klein, EA
Schellenger, JJ
Kolvenbag, GJCM
机构：
来源：
JOURNAL OF UROLOGY | 1998年 / 159卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1300
引用
收藏
页码：338 / 338
页数：1
相关论文
共 50 条
  • [41] Genomic mechanisms of resistance to neoadjuvant leuprolide plus abiraterone in locally advanced prostate cancer.
    Sowalsky, Adam G.
    Ye, Huihui
    Schaefer, Rachel J.
    Voznesensky, Olga S.
    Zhang, Zhenwei
    Lis, Rosina
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [42] Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine
    Fujimura, Tetsuya
    Takayama, Kenichi
    Takahashi, Satoru
    Inoue, Satoshi
    CANCERS, 2018, 10 (02)
  • [43] Sequential androgen blockade in patients with advanced prostate cancer - Open discussion
    Pienta, KJ
    Trachtenberg, J
    MOLECULAR UROLOGY, 1998, 2 (03) : 207 - 207
  • [44] ADVANTAGES OF TOTAL ANDROGEN BLOCKADE IN THE TREATMENT OF ADVANCED PROSTATE-CANCER
    GELLER, J
    ALBERT, J
    VIK, A
    SEMINARS IN ONCOLOGY, 1988, 15 (02) : 53 - 61
  • [45] Triple-arm androgen blockade for advanced prostate cancer: a review
    Desai, Milap H.
    Parsi, Meghana
    Potdar, Rashmika R.
    MEDICAL ONCOLOGY, 2021, 38 (07)
  • [46] Prolonged androgen blockade may boost survival in advanced prostate cancer
    不详
    ONCOLOGY-NEW YORK, 2000, 14 (05): : 772 - 772
  • [47] Triple-arm androgen blockade for advanced prostate cancer: a review
    Milap H. Desai
    Meghana Parsi
    Rashmika R. Potdar
    Medical Oncology, 2021, 38
  • [48] Maximum androgen blockade in advanced prostate cancer:: an overview of the randomised trials
    Dalesio, O
    van Tinteren, H
    Clarke, M
    Peto, R
    Schröder, FH
    Dechering, I
    Evans, V
    Godwin, J
    Blumenstein, BA
    Crawford, ED
    Denis, L
    Hall, R
    Hill, C
    Iversen, P
    Shipley, WU
    Soloway, M
    Sylvester, R
    LANCET, 2000, 355 (9214): : 1491 - 1498
  • [49] COMBINED TREATMENT (GOSERELIN PLUS FLUTAMIDE) VERSUS MONOTHERAPY (GOSERELIN ALONE) IN ADVANCED PROSTATE-CANCER - A RANDOMIZED STUDY
    JURINCIC, CD
    HORLBECK, R
    KLIPPEL, KF
    SEMINARS IN ONCOLOGY, 1991, 18 (05) : 21 - 25
  • [50] Efficacy and safety of first-line combined androgen blockade in advanced prostate cancer: A meta-analysis
    Sun, Y.
    Yang, Y.
    Chen, R.
    Zhao, L.
    Liu, F.
    Ren, S.
    Wang, H.
    Lu, X.
    Gao, X.
    Xu, C.
    ANNALS OF ONCOLOGY, 2017, 28
12345